BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12517655)

  • 1. Physician specialty is significantly associated with hormone replacement therapy use.
    Levy BT; Ritchie JM; Smith E; Gray T; Zhang W
    Obstet Gynecol; 2003 Jan; 101(1):114-22. PubMed ID: 12517655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy.
    Progetto Menopausa Italia Study Group
    Menopause; 2001; 8(4):290-5. PubMed ID: 11449088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional study of determinants of menopausal age and hormone replacement therapy use in Italian women.
    Amigoni S; Morelli P; Chatenoud L; Parazzini F
    Climacteric; 2000 Mar; 3(1):25-32. PubMed ID: 11910606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy menopause with a better future--a survey of views on hormone replacement therapy (HRT).
    Shafi S; Samad Z; Syed S; Sharif A; Khan MA; Nehal US; Siddiqui AR
    J Pak Med Assoc; 2001 Dec; 51(12):450-3. PubMed ID: 11850984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personal use of postmenopausal hormone replacement therapy by women physicians in the United States.
    McNagny SE; Wenger NK; Frank E
    Ann Intern Med; 1997 Dec; 127(12):1093-6. PubMed ID: 9412312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of information and HRT prescribing practices among gynecologists in Puebla, Mexico.
    Mueller KA; Sanchez GJ; Sievert LL
    Maturitas; 2003 Jun; 45(2):137-44. PubMed ID: 12787972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnic differences in hormone replacement prescribing patterns.
    Brown AF; PĂ©rez-Stable EJ; Whitaker EE; Posner SF; Alexander M; Gathe J; Washington AE
    J Gen Intern Med; 1999 Nov; 14(11):663-9. PubMed ID: 10571714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician gender and hormone replacement therapy discussion.
    Huston S; Sleath B; Rubin RH
    J Womens Health Gend Based Med; 2001 Apr; 10(3):279-87. PubMed ID: 11389788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discussion of hormone replacement therapy between physicians and their patients.
    Schneider AE; Davis RB; Phillips RS
    Am J Med Qual; 2000; 15(4):143-7. PubMed ID: 10948786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause.
    Kaplan B; Aschkenazi-Steinberg S; Yogev Y; Nahum R; Sulkes J; Phisher M
    Menopause; 2002; 9(5):354-9. PubMed ID: 12218724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen replacement therapy in patients with endometrial cancer: prescription attitude of Belgian gynecologists.
    Rozenberg S; Vasquez JB
    Maturitas; 2000 May; 35(2):125-8. PubMed ID: 10924838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What factors account for hormone replacement therapy prescribing frequency?
    Newton KM; LaCroix AZ; Buist DS; Anderson LA; Delaney K
    Maturitas; 2001 Jul; 39(1):1-10. PubMed ID: 11451615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and personal relationships between oral contraceptive and hormone replacement therapy use among US women physicians.
    Frank E; Elon L
    Menopause; 2003; 10(2):133-41. PubMed ID: 12627038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sociodemographic and clinical factors associated with HRT use in women attending menopause clinics in Italy.
    Pansini F; Bacchi Modena AB; de Aloysio D; Gambacciani M; Meschia M; Parazzini F; Sciacchitano G; di Micco R; Peruzzi E; Maiocchi G;
    Climacteric; 2000 Dec; 3(4):241-7. PubMed ID: 11910583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone replacement therapy use by older Mexican-American women.
    Newell DA; Markides KS; Ray LA; Freeman JL
    J Am Geriatr Soc; 2001 Aug; 49(8):1046-51. PubMed ID: 11555065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynecologists in Denmark, Norway and Sweden.
    Nilsen ST; Pedersen AT; Moen MH; Milsom I; Mattsson LA; Iversen OE; Larsen PM; Andersson K
    Maturitas; 2001 Jul; 39(1):83-90. PubMed ID: 11451625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.